Elevance Health (ELV) Other financing activities (2010 - 2026)

Elevance Health (ELV) has 15 years of Other financing activities data on file, last reported at -$3.0 million in Q1 2026.

• Quarterly Other financing activities rose 78.57% year-over-year to -$3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $33.0 million (up 306.25% YoY) and the FY2025 annual result came in at $22.0 million, up 1000.0% from the prior year.
• Other financing activities eased to -$3.0 million in Q1 2026 per ELV's latest filing, from $12.0 million in the prior quarter.
• Across five years, Other financing activities topped out at $25.0 million in Q4 2022 and bottomed at -$14.0 million in Q1 2025.
• The 5-year median for Other financing activities is $3.5 million (2023), against an average of $4.3 million.
• The widest annual swing landed in 2024, when Other financing activities slumped 450.0%; it then surged 2000.0% in 2025.
• Tracing ELV's Other financing activities over 5 years: stood at $25.0 million in 2022, then sank by 92.0% to $2.0 million in 2023, then tumbled by 450.0% to -$7.0 million in 2024, then surged by 271.43% to $12.0 million in 2025, then plunged by 125.0% to -$3.0 million in 2026.
• Per Business Quant, the three latest ELV Other financing activities figures stand at -$3.0 million (Q1 2026), $12.0 million (Q4 2025), and $21.0 million (Q3 2025).

Peer Comparison